C. Buhrer et al., The CRIB (Clinical Risk Index for Babies) score and neurodevelopmental impairment at one year corrected age in very low birth weight infants, INTEN CAR M, 26(3), 2000, pp. 325-329
Objective: To assess the ability of the Clinical Risk Index for Babies (CRI
B) to predict long-term neurodevelopmental impairment in very low birth wei
ght (VLBW) infants.
Design: Single-center cohort study.
Setting: Tertiary neonatal care hospital and follow-up clinic.
Patients: Four hundred fifty-five VLBW infants consecutively admitted from
1992 to 1997 inclusive.
Measurements and results: Calculations of CRIB scores from birth weight, ge
stational age, the presence of congenital malformations, worst base excess,
maximum and minimum appropriate fraction of inspired oxygen (FIO2) during
the first 12 h of life was possible in 430 infants. Three hundred eighty-si
x infants survived until discharge (89 %) and 352 (91 %) were examined at 1
year corrected age using the Griffiths scales of mental development. Major
neurodevelopmental impairment (general quotient < 2 standard deviations be
low average) was observed in 76 infants (22 %). CRIB scores and the individ
ual CRIB components differed significantly between infants with and those w
ithout neurodevelopmental impairment. By logistic regression analysis, CRIB
scores and minimum FIO2 were independent predictors of death, while CRIB a
nd maximum FIO2 were independently associated with neurodevelopmental impai
rment. For combined poor outcome (death or impairment), CRIB, minimum and m
aximum FIO2 were independent predictors. In predicting major neurodevelopme
ntal impairment, the area under the receiver operating characteristic curve
for CRIB (0.703 +/- 0.035) did not differ significantly from that of birth
weight (0.697 +/- 0.035) or any other CRIB component.
Conclusion: While high CRIB scores are associated with major neurodevelopme
ntal impairment, the CRIB score is of limited value for stratification in r
andomized trials or for adjustments in comparing performance between hospit
als with neurodevelopmental impairment as the main outcome measure.